Latest News about APRE
Recent news which mentions APRE
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 29, 2021
From Benzinga
48 Biggest Movers From Yesterday
September 29, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 21, 2021
From Benzinga
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
September 21, 2021
Tickers
APRE
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
From InvestorPlace
18 Stocks Moving in Tuesday's Pre-Market Session
September 21, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 20, 2021
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 20, 2021
From InvestorPlace
24 Stocks Moving in Monday's Pre-Market Session
September 20, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021
August 20, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2021
August 16, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 13, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 13, 2021
August 13, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 13, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 12, 2021
From Benzinga
Aprea Therapeutics Stock Drops On FDA Clinical Hold On Eprenetapopt Myeloid Malignancy Trials
August 06, 2021
Tickers
APRE
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
Aprea Stock Pops As Eprenetapopt Combo Regime Shows 58% Relapse-Free Survival, 79% Overall Survival At 1-Year Post-Transplant
July 21, 2021
Tickers
APRE
From Benzinga
Here's a list of stocks to watch next week
July 11, 2021
From AC Investor Blog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.